Effects of switching from twice-daily tacrolimus to once-daily extended-release meltdose tacrolimus on cellular immune response.

Front Transplant · 2024 · PMC11461451 · PMID 39386200

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significantno p-value reported

However, 4 weeks after switching to LCPT, there was a noteworthy decrease in non-suppressive Tregs (CD45RA − FoxP3 low ) and a borderline significant increase in resting Tregs (CD45RA + FoxP3 low ) ( Figures 2E–G ).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.